The Chemours Company announced its financial results for the fourth quarter and full year 2025, with net sales of $1.3 billion and $5.8 billion, respectively. The company reported a net loss attributable to Chemours of $47 million in Q4 and $386 million for the full year, primarily driven by lower cost absorption, non-cash inventory charges, and litigation-related expenses. Despite macroeconomic headwinds, Chemours anticipates 2026 net sales growth of 3-5% and adjusted EBITDA between $800 million and $900 million, supported by Opteon™ Refrigerants demand and strategic cost reductions.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
The Chemours Company Reports Fourth Quarter and Full Year 2025 Results
The Chemours Company announced its financial results for the fourth quarter and full year 2025, with net sales of $1.3 billion and $5.8 billion, respectively. The company reported a net loss attributable to Chemours of $47 million in Q4 and $386 million for the full year, primarily driven by lower cost absorption, non-cash inventory charges, and litigation-related expenses. Despite macroeconomic headwinds, Chemours anticipates 2026 net sales growth of 3-5% and adjusted EBITDA between $800 million and $900 million, supported by Opteon™ Refrigerants demand and strategic cost reductions.